Abbott Receives CE Mark for Next-Generation Navitor TAVI System to Treat Aortic Stenosis
Abbott’s Portico with Flexnav Tavr System Receives the US FDA’s Approval for the Treatment of Aortic Valve Disease
Shots:
- Abbott has received CE Mark for Navitor making the minimally invasive device available for people in Europe with severe aortic stenosis who are at high or extreme surgical risk
- Navitor uses Abbott’s FlexNav delivery system along with a unique design for preventing blood leaking around the valve to provide a less invasive alternative to surgical aortic valve replacement. The device features a NaviSeal fabric cuff that works as with the cardiac cycle to eliminate the backflow of blood around the valve (PVL)
- The Navitor valve paired with the FlexNav delivery system streamlines and simplifies TAVI procedures for physicians
Click here to read full press release/ article | Ref: Abbott | Image: Media Post